Brilinta is a popular brand medication offered by the leading pharmaceutical company, Astra Zeneca. It is an anti-platelet medication used to prevent heart attack. It is composed of active ingredient Ticagrelor. This medicine is available as a conventional tablet form dosage of 90 mg.
Manufacturer: Astra Zeneca
Active Ingredient: The main active component of the given medication is Ticagrelor, which is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. It has been linked to rare instances of hypersensitivity reactions accompanied by mild liver injury. It is a member of triazolopyrimidines, an organofluorine compound, an aryl sulfide, a secondary amino compound and a hydroxyether.
Indications: Ticagrelor composed medicine Brilinta is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems such as unstable angina, previous heart attack. It may also prevent blood clots after certain heart surgeries such as stent placement. It blocks platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in the body.
Action Mechanism: This mentioned medication is a blood-thinner used to reduce cardiovascular death and heart attack in people with acute coronary syndromes. Brilinta works by preventing the formation of new blood clots, thus maintaining blood flow in the body to help reduce the risk of another cardiovascular event.
Dosages: This anti-platelet medicine is available for oral consumption and in dosage as mentioned below:
- 90 mg: It is recommended to consume with or without food as directed by the doctor, usually twice a day
Note: Do not use this medicine just before heart bypass surgery or coronary artery bypass graft.